Clinical value of the integration of Prostate Health Index (PHI) in multiparametric MRI-based diagnostic strategies to detect clinically-significant prostate cancer. Results from the French prospective multicenter PHI-1 study

• V. Vlaeminck,
• X. Rebillard,
• P.J. Lamy,
• E. Potiron,
• P. Colin,
• J. Irani,
• M. Roumiguié,
• S. Vincendeau,
• O. Cussenot,
• M. Colombel,
• A. De La Taille,
• V. Delagarde,
• S. Lepers,
• J. Guechot,
• V. Armand-Labit,
• C. Bendavid,
• M. Dupuis,
• F. Subtil,
• L. Huot,
• A. Ruffion

Affiliations

V. Vlaeminck

X. Rebillard

P.J. Lamy

E. Potiron

P. Colin

J. Irani

M. Roumiguié

S. Vincendeau

O. Cussenot

M. Colombel

A. De La Taille

V. Delagarde

S. Lepers

J. Guechot

V. Armand-Labit

C. Bendavid

M. Dupuis

F. Subtil

L. Huot

A. Ruffion